Early Times Report NEW DELHI, Feb 13: The National Institute of Pharmaceutical Education and Research (NIPER) has introduced a new credit-based course titled Yoga and Meditation (GE 650) as part of its Pharmaceutical Curriculum for the academic year 2025-2026. The course will be conducted from 12 February to 03 March 2026 under the kind guidance of Swami Tyagrajananda Saraswati from the Bihar School of Yoga, Munger, Bharat. The course is being offered under the General Elective (GE) category. Swami Tyagrajananda Saraswati is an accomplished yoga master and a devoted sanyasi from the Satyananda Yoga/Bihar Yoga tradition. A dedicated practitioner of classical disciplines including Kriya Yoga, Tantra Yoga, Hatha Yoga, Raja Yoga, Naad Yoga, and Bhakti Yoga, he presently leads the life of a wandering sanyasi, committed to propagating the teachings of his masters and preserving the authentic yogic tradition. This initiative reflects NIPER's commitment to holistic education by integrating physical well-being, mental resilience, and stress management practices into professional pharmaceutical training. On this occasion, Dulal Panda, Director, and Kulbhushan Tikoo, Dean, NIPER, emphasized the importance of incorporating Yoga and Meditation into the academic framework. They highlighted its role in enhancing overall health, concentration, emotional balance, and productivity. By incorporating evidence-based yogic practices and meditation techniques, the program aims to support students in managing academic stress while fostering mindfulness and inner discipline. For this activity, the NIPER Yoga and Meditation Committee has made extensive efforts to ensure active participation and to facilitate proper arrangements for all students and NIPER residents. This initiative presents a valuable opportunity for everyone to engage in yogic practices and work towards achieving holistic health and balance within the NIPER campus. Through this program, NIPER continues to align academic excellence with personal development, preparing future pharmaceutical professionals to uphold both scientific rigor and personal well-being. |